Northern Trust Corp Oncocyte Corp Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.2 - $0.49 $2,777 - $6,805	-13,888 Reduced 6.65%	194,911 $68,000
Q2 2022 Aug 12, 2022	SELL	$0.86 - $1.53 $295,074 - $524,958	-343,110 Reduced 62.17%	208,799 $188,000
Q1 2022 May 13, 2022	SELL	$1.15 - $2.25 $35,227 - $68,924	-30,633 Reduced 5.26%	551,909 $822,000
Q4 2021 Feb 08, 2022	SELL	$2.04 - $3.59 $25,269 - $44,469	-12,387 Reduced 2.08%	582,542 $1.26 Million
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $769,423 - $1.28 Million	-217,967 Reduced 26.81%	594,929 $2.12 Million
Q2 2021 Aug 13, 2021	BUY	$3.77 - $6.0 $265,913 - $423,204	70,534 Added 9.5%	812,896 $4.67 Million
Q1 2021 May 12, 2021	BUY	$2.39 - $6.5 $152,343 - $414,323	63,742 Added 9.39%	742,362 $3.85 Million
Q4 2020 Feb 11, 2021	BUY	$1.38 - $2.63 $17,596 - $33,535	12,751 Added 1.91%	678,620 $1.62 Million
Q3 2020 Nov 16, 2020	BUY	$1.2 - $1.89 $206,204 - $324,771	171,837 Added 34.78%	665,869 $926,000
Q2 2020 Aug 14, 2020	BUY	$1.91 - $3.45 $380,208 - $686,763	199,062 Added 67.49%	494,032 $944,000
Q1 2020 May 14, 2020	BUY	$1.76 - $3.02 $73,772 - $126,586	41,916 Added 16.56%	294,970 $723,000
Q4 2019 Feb 14, 2020	BUY	$1.51 - $2.27 $5,087 - $7,647	3,369 Added 1.35%	253,054 $569,000
Q3 2019 Nov 13, 2019	BUY	$1.59 - $2.51 $279,382 - $441,037	175,712 Added 237.54%	249,685 $524,000
Q2 2019 Aug 13, 2019	BUY	$2.49 - $5.45 $45,069 - $98,645	18,100 Added 32.39%	73,973 $184,000
Q1 2019 May 13, 2019	BUY	$1.47 - $5.91 $60,264 - $242,286	40,996 Added 275.57%	55,873 $220,000
Q3 2018 Nov 14, 2018	BUY	$2.2 - $3.45 $10,296 - $16,146	4,680 Added 45.9%	14,877 $37,000
Q2 2018 Aug 14, 2018	SELL	$2.0 - $3.3 $67,734 - $111,761	-33,867 Reduced 76.86%	10,197 $26,000
Q1 2018 May 09, 2018	BUY	$1.25 - $4.6 $20 - $73	16 Added 0.04%	44,064 $92,000
Q4 2017 Feb 14, 2018	BUY	$3.9 - $7.4 $499 - $947	128 Added 0.29%	44,048 $205,000
Q3 2017 Nov 13, 2017	BUY	$4.55 - $7.55 $199,836 - $331,596	43,920	43,920 $331,000

Others Institutions Holding OCX

# of Institutions

Shares Held

399K

Call Options Held

Put Options Held

View Full List

About Oncocyte Corp

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $241M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

More about OCX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account